[Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000401:mortality; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D044140:Receptor, Angiotensin, Type 1; D015996:Survival Rate; D013599:Systole / Q000187:drug effects*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1; D001262:Atenolol; D019808:Losartan